1250736 min minutes 220 1251176 Min multiple intestinal neoplasia 102 1250830 min minimum 98 1250933 min 30min 16 1250837 MIN minimal 16 1251031 min mean operation time 11 1250734 min minimum, E 11 1250967 min median C 7 1251104 min m i n $(C)_ 6 1250932 min 30-minute 5 1251043 min meal duration 4 1251010 min mean time 4 1250896 min Mean procedural time 3 1250815 min minimum at T 3 1251102 min inter-meal interval 2 1251109 min m i n $sigma _ 2 1251025 min mean duration 2 1251006 min mean tacrolimus C 2 1251009 min mean treatment times 2 1250966 min median difference 2 1250968 min median NFV C 2 1251129 min median plasma C 2 1250897 min median recovery time 2 1250912 min MIC and C 2 1250863 min min $$ (T)_ 2 1250861 min min. predicted by equation: Race time 2 1250822 min minimal plate heights around h 2 1250821 min minimal traveling time t 2 1250833 min minimization 2 1250775 min minimum at concentration c 2 1250790 min minimum detectable absorption coefficients, alpha 2 1250795 min minimum detectable change in the absorption coefficient, alpha 2 1250798 min minimum frequency, f 2 1250803 min minimum group size n 2 1250781 min minimum phase velocity c 2 1251153 min molting, alpha 2 1251131 min monitoring of imatinib C 2 1251149 min more surface active at higher temperatures, indicated by lower ST 2 1251133 min morning stiffness 2 1251098 min mouse colonic epithelial (IMCE) cells carrying the APC 2 1251174 min multiplied by the session's duration 2 1251173 min ultra-marathon race time 2 1250943 min 120-min 1 1251095 min c-Myc expression in APC 1 1251096 min co-morbidities in Apc 1 1250941 min Fifteen-minute 1 1251097 min half-marathon race time 1 1250942 min HDAC2-mutant with tumor-prone APC 1 1251103 min intestinal mucosa of Apc 1 1250937 min Kaplan-Meier analysis and Cox proportional hazards regression demonstrated C 1 1251110 min m i n / a m a x $a_ 1 1250938 min M, the in-room time between fractions, td 1 1250939 min M. hirsutus may expand northward because of the lower T 1 1250940 min MAC of isoflurane without ketamine, MAC 1 1251112 min magnetic bead-based purification, using time-to-positive 1 1251105 min magnetic flux resolution is phi 1 1251106 min magnetic nano composite adsorbent under optimized parameters of contact time 1 1251107 min magnitude of dP/dt 1 1251108 min magnitude of the D/D 1 1251113 min main measure of outcome was the time to discharge 1 1250934 min MAIN OUTCOME MEASURES: Duration 1 1251114 min main parameters including ultrasound time 1 1251084 min main source of the paradoxical variability in C 1 1251079 min maintain a constant MOS 1 1251080 min maintain stroke volume and stroke work if E 1 1251081 min maintained an adequate VPA C 1 1251082 min maintaining a C 1 1251075 min maintaining acceptable C 1 1251076 min maintaining significantly higher C 1 1251077 min maintenance COD consumption ratio S 1 1251078 min maintenance of C 1 1250927 min Maintenance over time of C 1 1251083 min majority of LRTI patients, fC 1 1251093 min make future applications of the (sigma(u)A) 1 1251094 min malignant and benign breast lesions, the value of APT 1 1251089 min mammary hyperplasias and carcinomas in Apc 1 1251090 min mammary tumor onset in Apc 1 1251091 min mammary tumor predisposition in Apc 1 1251092 min management data included procedure time 1 1251085 min manipulated to remove data containing bands from the 0-120 1 1251086 min manufacturing, such as polymer solution concentration (w/v%), spinning time 1 1250935 min MAP kinase 1 1251087 min marginal doses, namely D 1 1251088 min markers of left ventricular relaxation, dP/dt 1 1251062 min markers, operation time 1 1251063 min marrow, which was of short duration 1 1251064 min mass (g), treatment time 1 1251058 min mass contained within r 1 1251059 min mass index (kg.m-2; BMI) and MRW time 1 1251060 min mass index differed significantly; saquinavir C 1 1251061 min mass index was associated with lower atazanavir C 1 1251055 min mass localization, intraoperative time 1 1251056 min mass were independently associated with intraoperative difficulty: Operative time 1 1251057 min mass-focusing for a mass range of (m/z)max/(m/z) 1 1251071 min matched at the same time point 1 1251072 min matched with the findings of impaired BAT function in APC 1 1250936 min MATERIALS AND METHODS: The time 1 1251073 min maximal diene production 1 1251074 min maximal heights grow logarithmically with the tree size, N, h 1 1251067 min maximal linear size of the prostate; S 1 1251068 min maximal workload and test duration 1 1251069 min maximum aortic lumen diameter, and D 1 1251070 min maximum concentration (Cmax), and C 1 1251065 min maximum dose for OARs, treatment delivery time 1 1250928 min Maximum increases in RMR 1 1251066 min maximum sedentary bouts 1 1251044 min maximum speed (km h), duration since previous sprint 1 1251040 min may be appropriate in certain patients with C 1 1251041 min may be helpful in ensuring C 1 1251042 min may even lead to an erroneous determination of the PMI 1 1250929 min May-Grunwald stain showed a prolonged CYCLE 1 1250918 min MD value of levodopa onset time 1 1250919 min MDA, inducible nitric oxide synthase and hydroxyproline content, increasing -dp/dt 1 1250930 min Meal intake (g) and meal time 1 1251036 min meals per day, feeding time per meal 1 1251037 min mean (+/- SD) IDV C 1 1251038 min mean (SD) 12-hour tacrolimus C 1 1250923 min Mean (standard deviation) CV% values for C 1 1251039 min mean +/- standard deviation atazanavir C 1 1251045 min mean ablation time 1 1251046 min mean absolute deviation of the V 1 1250926 min Mean annual change in MVPA time 1 1251047 min mean aortic blood pressure and LVdP/dt 1 1250922 min Mean aripiprazole plasma C 1 1251048 min mean atazanavir C 1 1251016 min mean basking durations 1 1251017 min mean cardiopulmonary bypass time 1 1251018 min mean changes in S 1 1251019 min mean circulation arrest time 1 1251022 min mean daily duration 1 1250901 min Mean daily MVPA 1 1251023 min mean daily tacrolimus C 1 1251024 min mean difference 1 1250902 min Mean divalproex C 1 1251020 min mean duration from collapse to arrival at ED 1 1251021 min mean duration of sensory block 1 1251030 min mean duration of subsequent surgery 1 1251026 min mean duration of surgery 1 1251027 min mean durations (+/- S.D.) 1 1250900 min Mean fluoroscopy time 1 1250924 min Mean FU imatinib C 1 1251035 min mean GCIPLminimum 1 1251053 min mean GEI scores were (28.36.6) for 0-30minute 1 1250925 min Mean IAP 1 1251054 min mean IM-C 1 1251028 min mean increase in cyclosporine C 1 1251029 min mean initial C 1 1251032 min mean irradiation time 1 1251049 min mean IT 1 1251033 min mean laser time 1 1251034 min mean operating room time 1 1251050 min mean OR time 1 1251051 min mean PA bouts duration 1 1251002 min mean pre-hospital time intervals 1 1250999 min mean procedure time and ranges for each section 1 1251052 min mean R-R interval and the duration 1 1251000 min mean ratio of IDV C 1 1250898 min Mean removal time 1 1250899 min Mean renal and intrarenal V 1 1251001 min mean residence time, was applied to estimate N 1 1251003 min mean retention times 1 1250909 min Mean skin-to-skin times 1 1250910 min Mean sorafenib C 1 1251004 min mean step count and time spent 1 1251005 min mean summation of complete hemostasis 1 1250911 min Mean test duration 1 1250906 min Mean time for harvesting and closing 1 1250907 min Mean time in the infusion chair 1 1251011 min mean time of discharge from PACU 1 1251012 min mean time of the first analgesic 1 1251007 min mean time spent 1 1250908 min Mean total active HCP time 1 1251008 min mean total operative time 1 1250903 min Mean tumor suppressive whole-blood C 1 1250904 min Mean warm ischemia time 1 1251013 min measure of the substituent effect, DeltaV 1 1251014 min measure the electron density profile with the resolution ne 1 1251015 min measure was operative time based on the following categories 1 1250983 min measured between the drying rate 1 1250984 min measured by post-interventional dP/dt 1 1250985 min measured for a wide range of 3-D directions. d 1 1250986 min measured from a single frame corresponding to D 1 1250979 min measured in terms of d(X), rho(r), or V 1 1250980 min measured local prolongation of VGL 1 1250981 min measured simultaneously with good time resolution 1 1250982 min measured: total sleep duration 1 1250987 min measurement (antecubital fossa/upper arm), occlusion site (lower/upper arm), occlusion duration 1 1250988 min measurement is thus only remotely informative about C 1 1250998 min measurements for time in bed 1 1250920 min MEASUREMENTS: Time taken to achieve initial control 1 1250905 min Measures of diastolic function, dP/dt 1 1250993 min measures were age, gender, duration of surgery, operating time 1 1250994 min measures were bleeding (L), operation time 1 1250921 min MEASURES: Primary efficacy end points were stopwatch-assessed duration of erection 1 1250914 min MEASURES: The Pittsburgh Rehabilitation Participation Scale and time in therapy 1 1250995 min measures: total time in bed 1 1250996 min mechanical output is exactly the W 1 1250989 min mechanical ventilation time 1 1250990 min mechanisms responsible for the insect CT 1 1250991 min mechanisms that accelerate the system towards consensus close to Deltaeta_ 1 1250992 min mechanisms underlying plasticity in CT 1 1250997 min median 1 1250970 min median (absolute) unbound C 1 1251118 min Median (interquartile range) C 1 1250971 min median (interquartile range) lopinavir C 1 1251115 min Median (interquartile range) rosuvastatin C 1 1251116 min Median (range) piperacillin C 1 1251120 min Median antiretroviral C 1 1251121 min Median cardiopulmonary bypass, cardiac ischaemic, circulatory arrest and ACP times 1 1250965 min median cyclosporine C 1 1251122 min Median difference time to knee extension 1 1251123 min Median fluoroscopy and procedure times 1 1251117 min Median IELT 1 1250976 min median imatinib C 1 1251119 min Median intubation time 1 1250977 min median lopinavir study-state C 1 1250978 min median of lag time 1 1251128 min Median plasma ATV C 1 1250975 min median time from on-scene EMS arrival to hospital arrival 1 1251124 min Median time to first PO 1 1250972 min median time to initial epinephrine administration 1 1250969 min median TTA delivery 1 1250964 min median TTP 1 1250973 min medication on the total sleep time 1 1250974 min meeting the condition theta 1 1251125 min Melagatran prolonged time to occlusion 1 1250915 min MELD (HR 1.064, 95%CI 1.025-1.104; P=0.001) and operation duration 1 1250950 min membrane lipids to penetrate interfacial films and raise gamma 1 1250951 min membrane thickness lambda 1 1250952 min membrane traffic upon short term 1 1250953 min membranes with alpha > alpha 1 1250946 min men and women finishers with race time 1 1250947 min meropenem was suppressed with a C 1 1250948 min metabolic disorder phenotype in APC 1 1250949 min metabolic disorders are present in APC 1 1250944 min metabolic equivalent tasks 1 1250945 min metabolism in APC 1 1250963 min metaboreflex activation did not elicit significant changes in either -dl/dt 1 1250959 min metal to phosphorus pi-back-bonding, the DeltaE and V 1 1250960 min methadone oral solution: C 1 1250961 min methanol (%), the duration 1 1250962 min methanol (wt./v), reaction time 1 1250955 min methanol composition (v/v, %), solid-solvent ratio (g/mL), time 1 1250956 min method: individual C 1 1250916 min METHODS: Steady-state imatinib C 1 1250917 min METHODS: Two nephrologists evaluated BIS, ULCs, IVCD during inspiration 1 1250957 min methylation status, contrast enhancement, initial treatment, and TTP 1 1250958 min metric and time 1 1250954 min metrics including minimum 1 1250876 min mg plus omeprazole reduced atazanavir AUC and C 1 1250877 min mg protein/hr 1 1250878 min mg/d, imatinib C 1 1250913 min MIC for the organism responsible for infection; i.e., C 1 1250882 min mice but had no effect on f 1 1250883 min mice carrying the Apc 1 1250884 min mice with carcinogens and breeding to the Apc 1 1250885 min mice with decompression hypoxia 1 1250879 min micro M. h, and a C 1 1250880 min microg/L and half the patients had a C 1 1250881 min microg/ml; and C 1 1250886 min microl, lopinavir C 1 1250887 min microm, the distance r 1 1250888 min microns in diameter ten minutes 1 1250889 min microstructure; snack duration 1 1250892 min microwave or pressure cooker treatment, with neither CYCLE 1 1251126 min Microwave power (W) and heating time 1 1250893 min microwave power (W) and time 1 1250894 min microwave power (W), and extraction time 1 1250895 min microwave-assisted extraction parameters such as extraction time (t) 1 1250890 min mid-morning sample, and C 1 1250891 min might be expected from the lower bound alpha 1 1250857 min migraine frequency (days/month), average duration 1 1250858 min migration time 1 1250859 min milking time 1 1250860 min milliseconds, T 1 1250864 min min by dividing undergone distance (m) and time 1 1250865 min min from time(-30) 1 1250866 min min time-response curve as % PNIF change 1 1250862 min min with Rmin or A 1 1250871 min min, and CT 1 1250872 min min, enough piperacillin C 1 1250867 min min, gamma 1 1250868 min min, half-time 1 1250869 min min, number of PA bouts, total duration of PA bouts 1 1250870 min min, time taken for pre-hydration 1 1250874 min min-1 over 10 1 1250873 min min-1 X ml-1 100,000-g supernatant vs. time 1 1250875 min min. for a time 1 1250841 min mini-exon gene 1 1250842 min miniature 1 1250843 min minima at a certain temperature, T 1 1250838 min minimal 5-gene cluster 1 1250844 min minimal absorption coefficient alpha 1 1250845 min minimal amplitude, A_ 1 1250846 min minimal center-of-mass temperatures comparable to T_ 1 1250851 min minimal detectable change in absorption cross section, sigma 1 1250852 min minimal dysplasia 1 1250853 min minimal focal length value f 1 1250839 min minimal Hamming distance, H 1 1250854 min minimal immediate early cytomegalovirus promoter (CMV) 1 1250840 min minimal LA volume or Vol 1 1250847 min minimal local growth exponent alpha 1 1250848 min minimal margin that yielded D 1 1250849 min minimal molecular area A 1 1250850 min minimal number of layers L 1 1250855 min minimal number of surviving organisms-N 1 1250856 min minimal pH change deltapH 1 1250823 min minimal possible temperature T 1 1250824 min minimal pressure increase dP/dt 1 1250825 min minimal reduced plate height values of h 1 1250818 min minimal reduced plate height values of the order of h 1 1250819 min minimal separation impedance E 1 1250820 min minimal traveling time and find l 1 1250835 min minimal value alpha 1 1250826 min minimal value A_ 1 1250836 min minimal velocities satisfy a general duality relation, v 1 1250831 min minimal work needed to reach T 1 1250832 min minimal work that is needed, W 1 1250834 min minimize the reduction in D 1 1250827 min minimize these influences, simulation results suggest the evaluation of dQ/dt 1 1250828 min minimizes the folding characteristic time tau 1 1250829 min minimizes the three characteristic times differs from the value alpha 1 1250806 min minimum allowed degree K_ 1 1250807 min minimum and maximum critical thermal limits, CT 1 1250816 min minimum at a density rho 1 1250817 min minimum at about T 1 1250814 min minimum at Deltaeta_ 1 1250812 min minimum at lambda 1 1250813 min minimum baryon number A 1 1250810 min minimum contact angle theta 1 1250811 min minimum core radius, R 1 1250796 min minimum dimension d_ 1 1250797 min minimum distance 1 1250791 min minimum dose D 1 1250792 min minimum drug plasma concentrations, C 1 1250793 min minimum energy location Z 1 1250794 min minimum foreshock magnitude m 1 1250799 min minimum fundamental frequency observed in a given sample 1 1250804 min minimum hardness H 1 1250808 min minimum Ic, Ic 1 1250805 min minimum in the q profile, q 1 1250800 min minimum interelectrode separation distance, L(p) > or = lambda(m)-d 1 1250801 min minimum load L 1 1250802 min minimum local volume fraction _ 1 1250771 min minimum mass, M 1 1250809 min minimum MFPT of BRWs, tau_ 1 1250772 min minimum noise figure NF 1 1250773 min minimum norm (number of atoms), N = N 1 1250774 min minimum number of connections for a node varies from k 1 1250777 min minimum oesophageal pressure; Poes 1 1250778 min minimum of Ca-channel current, T 1 1250779 min minimum of the electrostatic potential V 1 1250780 min minimum particle size R 1 1250776 min minimum perceptible thickness difference DeltaX 1 1250785 min minimum period T 1 1250782 min minimum plasma glucose level appeared, T 1 1250783 min minimum plate height H 1 1250784 min minimum pressures P 1 1250787 min minimum radius R 1 1250788 min minimum reduced plate height, h 1 1250789 min minimum relative supersaturation ratio, sigma 1 1250786 min minimum required preionization level n 1 1250755 min minimum resolvable angle, alpha 1 1250756 min minimum scale size L 1 1250751 min minimum scanning velocity, nu 1 1250752 min minimum separation between elements z 1 1250753 min minimum singular value lamda_ 1 1250754 min minimum slightly above T_(c) with eta/s|_ 1 1250757 min minimum subcutaneous fat thickness: S 1 1250758 min minimum surface area demand per molecule adsorbed, A 1 1250759 min minimum surface areas per surfactant A 1 1250760 min minimum surface tension gamma 1 1250765 min minimum temperature T particle 1 1250766 min minimum temperature, Tc 1 1250767 min minimum threshold value chi_ 1 1250761 min minimum time delay between the BIS and F 1 1250762 min minimum total measurement time T 1 1250763 min minimum tracking latency VGL 1 1250764 min minimum travel time between the wells is denoted t 1 1250768 min minimum value of about h 1 1250769 min minimum value of the gap, Delta_ 1 1250770 min minimum value, a 1 1250737 min minimum zero-bias conductance, G 1 1250738 min minimum, corresponding to a region where the magnitude of W 1 1250735 min minute ventilation was still present when PS 1 1250739 min minutes after exposure end 1 1250740 min minutes of reperfusion the dP/dt 1 1250750 min minutes, DI 1 1250745 min missions by the parameters of duration 1 1250746 min mix, ultrasonication time 1 1250747 min mixed-effect linear model was developed with the log D-value 1 1250748 min mixing loads (yes/no), transport duration 1 1250741 min mixing regime, mu 1 1251127 min Mixing Time 1 1250742 min mixture in the S 1 1250743 min mm in the CV 1 1250744 min mmHg, while V(E), tidal volume and Poes 1 1250749 min mmol/h (12.4-19.1) in TSC/Ca 1 1250722 min model and of the geometric critical exponents d_ 1 1250723 min model for pancreatic ductal adenocarcinoma, and the APC 1 1250718 min model for thermal treatment time 1 1250719 min model is equivalent to site percolation with chi_ 1 1250720 min model is so defined from only three parameters: Aw 1 1250721 min model of power and time: log10cm3=-0.0546+ 0.0485 total time 1 1250714 min model predicts compressive strength better than the (sigma(u)A) 1 1250715 min model rather than to the exact timing of x 1 1251130 min Model simulations revealed interplay between fast 1 1250716 min model systems show excellent linear correlation between V 1 1250717 min model was tested in nine patients with C 1 1250731 min model, but enhanced tumorigenesis in the APC 1 1250732 min modeled as a cubic curve with the equation: CUSUM 1 1250733 min modeled as a second-order polynomial with equation CUSUM 1 1250727 min modeled as a second-order polynomial with the following equation: CUSUMOT 1 1250728 min modeling of the stirring time 1 1250729 min models (i), (ii), and (iii) are V 1 1250730 min models are encouraging, due to a short lifespan 1 1250724 min models characterized by linear and nonlinear pressure-flow characteristics. dQ/dt 1 1250725 min models predicted phase durations: nitrification time 1 1250726 min moderate exercise, except there were significant changes in both -dl/dt 1 1251160 min moderate hepatic impairment were, respectively: C 1 1251159 min modification in MG 1 1251162 min modification process was a first-order reaction with respect to time 1 1251161 min modified to attain sufficient C 1 1251156 min modified-calcium diet in Apc 1 1251155 min modifies susceptibility to intestinal cancer in Apc 1 1251158 min molecular replacement, anomalous dispersion and R 1 1251157 min molecule leads to enhanced colonic polyposis in Apc 1 1251154 min molecule per signal duration 1 1251142 min monitored and completion times were recorded 1 1251140 min monitored to reveal N(w) 1 1251139 min monitoring (TDM) of plasma C 1 1251141 min monitoring of vital signs, we recorded the atropinization time 1 1251136 min monitoring time 1 1251135 min monitoring using the C 1 1251138 min monkey, and albino rats; however, dark-adapted P 1 1251137 min monodentate phosphine ligands reveals distinct regioselectivity cliffs, and % Vbur 1 1251134 min monoligated metal and that %Vbur 1 1251132 min Monte Carlo study of the shortest-path fractal dimension d 1 1251152 min month, and ROC analysis demonstrated C 1 1251151 min months for patients in the lowest C 1 1251148 min morbidity, CT imaging studies per provider, time in ED 1 1251147 min morbidity, readmissions, operative time 1 1251150 min morcellation time 1 1251144 min more damage in the Fluid 1 1251143 min more frequently associated with C 1 1251146 min more in the Fluid 1 1251145 min more informative than the H 1 1251199 min more significant increases in CAC and A 1 1251200 min morning C 1 1251196 min morning GH injections, respectively; total sleep time 1 1251099 min Morphological studies identified that the brown adipocytes of APC 1 1251198 min morphologically normal colonic mucosa (MNCM) of APC 1 1251197 min mortality, duration of operation, duration of anaesthesia 1 1251194 min mosaic with a constant d 1 1251193 min most constraining result is obtained at M_ 1 1251195 min most negatively charged atom, delta 1 1251207 min most nitroxides short exposures to light 1 1251206 min most of the variability in C 1 1251209 min most recent Army Physical Fitness Test TMR time 1 1251208 min motility, levodopa absorption diminishes, and final concentrations and C 1 1251204 min motion, as quantified by D_ 1 1251203 min motion, plasma creatine kinase activity, muscle soreness, TOI 1 1251205 min mouse beta-globin locus control region preferentially reduce beta 1 1251202 min mouse colonocytes, but its over-expression in cells harboring Apc 1 1251201 min movement time 1 1251175 min moving phase (p>p(c)) where the velocity v 1 1251111 min mRNA were also detected in APC 1 1250931 min MRSA infections, recommended C 1 1251181 min mucosa in APC 1 1251180 min mucosal bleeding time 1 1251183 min multiligand complexes with circular dichroism negative extremum at lambda 1 1251182 min multiple combinations of epsilon and R 1 1251177 min multiple factors examined, only the C 1 1251179 min multiple regression equation: lag time 1 1251178 min multiplied by the duration 1 1251184 min multiplying RPE by session duration 1 1251190 min multitract, bodymass index and surgical time 1 1251189 min multivariate analyses, LAV 1 1251192 min multivariate analysis demonstrated that only CP 1 1251100 min Multivariate analysis identified that bypass time 1 1251191 min multivariate analysis, procedure time 1 1251186 min multivariate logistic regression analysis, only the C 1 1251185 min mumol/L, the synergism effect was the most obvious, CI 1 1251188 min muscle evoked by nerve stimulation: the time 1 1251187 min muscle stimulation group had statistically significant differences in SCL 1 1251163 min muscles from failing hearts. cAMP and caffeine both shifted f 1 1251165 min muscles, we assessed crossbridge kinetics indirectly by determining f 1 1251164 min must be of a thickness > or =D 1 1251170 min mutations, TPV C 1 1251169 min myeloproliferative phenotype resulting from the transplantation of defective Apc 1 1251172 min myocardial infarction, the average value of V(p) decreased, while dP/dt 1 1251171 min myocardium, the clearance half time 1 1251101 min O6-methylguanine-DNA methyltransferase status, age, and TTP 1 1251167 min one-minute 1 1251166 min phosphine-metal coordination chemistry, the V 1 1251168 min three-dimensional identical nonoverlapping spheres within a radius R 1